Effects of L-thyroxine in rats with chronic heart failure after myocardial infarction

R. Gay, T. A. Gustafson, Steven Goldman, E. Morkin

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The effects of thyroid hormone on left ventricular (LV) function and myosin isoenzyme distribution were evaluated in rats 3 wk after myocardial infarction. When compared with normal rats, animals selected for study had moderately severe LV dysfunction as judged by decreased aortic and LV systolic pressures and a 34% decrease in LV maximum rate of pressure development (dP/dt). Average LV end-diastolic pressure was increased to 26 ± 1 mmHg from 5 ± 1 mmHg. The infarcted rats were divided into saline-treated control (n = 10) and treatment (n = 13) groups. The latter group received thyroxine (T4, 1.5 μg/100 g body wt) immediately after the first determination of pressures and at 24 and 48 h. At 72 h, aortic and LV pressures and myosin isoenzyme composition were measured. In the thyroxine-treated group LV end-diastolic pressure decreased from 27 ± 2 to 18 ± 2 mmHg, and LV dP/dt increased from 5,627 ± 249 to 6,064 ± 355 mmHg/s. Heart rate and aortic pressure did not change. After saline injections, LV end-diastolic pressure remained elevated, and the other hemodynamic parameters were unchanged. Determination of ventricular myosin isoenzyme composition in the saline-treated group revealed an increase in the V3 myosin isoform and a decrease in the V1 isoform as compared with the normal values. This pattern was not altered by T4 treatment. A separate group (n = 7) of rats was treated with a 10 times larger dose of thyroxine (15 μg/100 g body wt) for the same period of time. In this group, there was neither hemodynamic improvement nor changes in myosin isoenzyme distribution. Thus in this model of chronic heart failure short-term treatment with low doses of T4 produces improvement in LV performance before changes are observed in myosin isoenzymes.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume253
Issue number2
StatePublished - 1987
Externally publishedYes

Fingerprint

Ventricular Myosins
Thyroxine
Isoenzymes
Heart Failure
Myocardial Infarction
Blood Pressure
Ventricular Pressure
Myosins
Protein Isoforms
Hemodynamics
Pressure
Left Ventricular Dysfunction
Thyroid Hormones
Left Ventricular Function
Arterial Pressure
Reference Values
Therapeutics
Heart Rate
Injections

ASJC Scopus subject areas

  • Physiology

Cite this

Effects of L-thyroxine in rats with chronic heart failure after myocardial infarction. / Gay, R.; Gustafson, T. A.; Goldman, Steven; Morkin, E.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 253, No. 2, 1987.

Research output: Contribution to journalArticle

@article{ebe503a7fdaa4bbf9631e466ad7297a1,
title = "Effects of L-thyroxine in rats with chronic heart failure after myocardial infarction",
abstract = "The effects of thyroid hormone on left ventricular (LV) function and myosin isoenzyme distribution were evaluated in rats 3 wk after myocardial infarction. When compared with normal rats, animals selected for study had moderately severe LV dysfunction as judged by decreased aortic and LV systolic pressures and a 34{\%} decrease in LV maximum rate of pressure development (dP/dt). Average LV end-diastolic pressure was increased to 26 ± 1 mmHg from 5 ± 1 mmHg. The infarcted rats were divided into saline-treated control (n = 10) and treatment (n = 13) groups. The latter group received thyroxine (T4, 1.5 μg/100 g body wt) immediately after the first determination of pressures and at 24 and 48 h. At 72 h, aortic and LV pressures and myosin isoenzyme composition were measured. In the thyroxine-treated group LV end-diastolic pressure decreased from 27 ± 2 to 18 ± 2 mmHg, and LV dP/dt increased from 5,627 ± 249 to 6,064 ± 355 mmHg/s. Heart rate and aortic pressure did not change. After saline injections, LV end-diastolic pressure remained elevated, and the other hemodynamic parameters were unchanged. Determination of ventricular myosin isoenzyme composition in the saline-treated group revealed an increase in the V3 myosin isoform and a decrease in the V1 isoform as compared with the normal values. This pattern was not altered by T4 treatment. A separate group (n = 7) of rats was treated with a 10 times larger dose of thyroxine (15 μg/100 g body wt) for the same period of time. In this group, there was neither hemodynamic improvement nor changes in myosin isoenzyme distribution. Thus in this model of chronic heart failure short-term treatment with low doses of T4 produces improvement in LV performance before changes are observed in myosin isoenzymes.",
author = "R. Gay and Gustafson, {T. A.} and Steven Goldman and E. Morkin",
year = "1987",
language = "English (US)",
volume = "253",
journal = "American Journal of Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Effects of L-thyroxine in rats with chronic heart failure after myocardial infarction

AU - Gay, R.

AU - Gustafson, T. A.

AU - Goldman, Steven

AU - Morkin, E.

PY - 1987

Y1 - 1987

N2 - The effects of thyroid hormone on left ventricular (LV) function and myosin isoenzyme distribution were evaluated in rats 3 wk after myocardial infarction. When compared with normal rats, animals selected for study had moderately severe LV dysfunction as judged by decreased aortic and LV systolic pressures and a 34% decrease in LV maximum rate of pressure development (dP/dt). Average LV end-diastolic pressure was increased to 26 ± 1 mmHg from 5 ± 1 mmHg. The infarcted rats were divided into saline-treated control (n = 10) and treatment (n = 13) groups. The latter group received thyroxine (T4, 1.5 μg/100 g body wt) immediately after the first determination of pressures and at 24 and 48 h. At 72 h, aortic and LV pressures and myosin isoenzyme composition were measured. In the thyroxine-treated group LV end-diastolic pressure decreased from 27 ± 2 to 18 ± 2 mmHg, and LV dP/dt increased from 5,627 ± 249 to 6,064 ± 355 mmHg/s. Heart rate and aortic pressure did not change. After saline injections, LV end-diastolic pressure remained elevated, and the other hemodynamic parameters were unchanged. Determination of ventricular myosin isoenzyme composition in the saline-treated group revealed an increase in the V3 myosin isoform and a decrease in the V1 isoform as compared with the normal values. This pattern was not altered by T4 treatment. A separate group (n = 7) of rats was treated with a 10 times larger dose of thyroxine (15 μg/100 g body wt) for the same period of time. In this group, there was neither hemodynamic improvement nor changes in myosin isoenzyme distribution. Thus in this model of chronic heart failure short-term treatment with low doses of T4 produces improvement in LV performance before changes are observed in myosin isoenzymes.

AB - The effects of thyroid hormone on left ventricular (LV) function and myosin isoenzyme distribution were evaluated in rats 3 wk after myocardial infarction. When compared with normal rats, animals selected for study had moderately severe LV dysfunction as judged by decreased aortic and LV systolic pressures and a 34% decrease in LV maximum rate of pressure development (dP/dt). Average LV end-diastolic pressure was increased to 26 ± 1 mmHg from 5 ± 1 mmHg. The infarcted rats were divided into saline-treated control (n = 10) and treatment (n = 13) groups. The latter group received thyroxine (T4, 1.5 μg/100 g body wt) immediately after the first determination of pressures and at 24 and 48 h. At 72 h, aortic and LV pressures and myosin isoenzyme composition were measured. In the thyroxine-treated group LV end-diastolic pressure decreased from 27 ± 2 to 18 ± 2 mmHg, and LV dP/dt increased from 5,627 ± 249 to 6,064 ± 355 mmHg/s. Heart rate and aortic pressure did not change. After saline injections, LV end-diastolic pressure remained elevated, and the other hemodynamic parameters were unchanged. Determination of ventricular myosin isoenzyme composition in the saline-treated group revealed an increase in the V3 myosin isoform and a decrease in the V1 isoform as compared with the normal values. This pattern was not altered by T4 treatment. A separate group (n = 7) of rats was treated with a 10 times larger dose of thyroxine (15 μg/100 g body wt) for the same period of time. In this group, there was neither hemodynamic improvement nor changes in myosin isoenzyme distribution. Thus in this model of chronic heart failure short-term treatment with low doses of T4 produces improvement in LV performance before changes are observed in myosin isoenzymes.

UR - http://www.scopus.com/inward/record.url?scp=0023200269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023200269&partnerID=8YFLogxK

M3 - Article

C2 - 3618809

AN - SCOPUS:0023200269

VL - 253

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6143

IS - 2

ER -